Octagon Capital Advisors »

Tenaya Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Tenaya Therapeutics (TNYA) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Tenaya Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenaya Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenaya Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.0M 2.6M 3.10
2024-03-31 $15M 2.9M 5.23

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Structure Therapeutics Sponsored Ads (GPCR)
Dyne Therapeutics (DYN)
Arrivent Biopharma (AVBP)
Verona Pharma Sponsored Ads (VRNA)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)
Ocular Therapeutix (OCUL)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)

View all positions for Octagon Capital Advisors

Top funds holding Tenaya Therapeutics

Column Group
RA Capital Management
Casdin Capital
BlackRock
T. Rowe Price Associates
Vanguard Group
Octagon Capital Advisors
Citadel Advisors
VR Adviser
Ghost Tree Capital
Geode Capital Management
State Street Corporation
Euclidean Capital
Alphabet
Standard Life Aberdeen

View all funds holding Tenaya Therapeutics